Physician

Aamer A Qureshi, M.D.

According to 2025 Medicare claims, Aamer Qureshi, M.D. (NPI: 1043266943) practices cardiology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is MECKLENBURG HEART SPECIALISTS, P.A. (NPI: 1295772903; TIN: 562040160) and primary practice location at 28207-2027. Qureshi is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Qureshi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 317 traditional Medicare patients, billed 3,401 HCPCS/CPT codes, and received $441,379 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 3,265 prescription claims across 487 beneficiaries totaling $1,693,011 in drug costs, led by Uptravi (Selexipag). 2016 DME data shows 35 claims. Open Payments data shows 136 records totaling $9,290. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $435,493 and ending at $441,379. Concurrently, Part D prescription costs have risen steadily, from $1,061,939 to $1,693,011. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $4,218 to $802.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,143	9,620	$435,493
2016	1,113	11,548	$690,495
2017	1,254	9,237	$552,731
2018	1,170	5,924	$715,512
2019	945	5,763	$1,088,050
2020	900	4,199	$707,956
2021	852	4,269	$815,260
2022	493	3,474	$500,460
2023	341	3,272	$537,051
2024	317	3,401	$441,379

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	364	4,546	$1,061,939
2016	537	4,874	$1,269,736
2017	636	6,982	$1,729,166
2018	632	5,998	$1,399,074
2019	592	5,266	$1,335,530
2020	562	4,798	$1,585,296
2021	564	4,583	$1,782,811
2022	586	4,601	$2,407,031
2023	510	3,468	$2,243,802
2024	487	3,265	$1,693,011

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	90	$2,534
2016	N/R	35	$1,135
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	179	197	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	116	179	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	250	550	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	241	516	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	105	142	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Uptravi	Selexipag	12	360	$281,389
Opsumit	Macitentan	21	630	$266,490
Eliquis	Apixaban	264	12,238	$238,296
Adempas	Riociguat	14	390	$184,198
Xarelto	Rivaroxaban	177	9,030	$167,672

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	134	$4,110	Cook Medical LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$5,180	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aamer A. Qureshi, M.D.?

Tedicare shows public-source Medicare data for Aamer A. Qureshi, M.D. (NPI 1043266943), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aamer A. Qureshi, M.D. have ACO affiliation data?

Aamer A. Qureshi, M.D. is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Aamer A. Qureshi, M.D.?

Aamer A. Qureshi, M.D. is linked to MECKLENBURG HEART SPECIALISTS, P.A. (billing NPI 1295772903) in the available physician profile data.

Does Aamer A. Qureshi, M.D. have Open Payments data?

Aamer A. Qureshi, M.D. has 136 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.